Alexion Launches 2020 CSR Report Written From Employee Perspective

Alexion, a global biopharmaceutical company, is committed to all the communities we engage with including patients, caregivers and their families; our valued employees and future talent; our neighbors around the world; investors; patient organizations; suppliers; business partners and others. This collective passion comes to life in our 2020 Corporate Social Responsibility (CSR) report, Dear Communities, which is written from the first-person perspective of Alexion employees. Alexion CEO Ludwig Hantson embodies the personal tone in his opening words: “There is no doubt that 2020 was a year of change – it…

Read More

Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees

 Alexion Pharmaceuticals, Inc. has announced the launch of the Alexion Charitable Foundation to provide further support for the rare disease community and for local communities which the company serves. The key components of the Foundation are the Rare Belonging™ and Local Needs Grants focus areas. Rare Belonging seeks to advance emotional well-being and educational opportunities, and provide relief for critical needs, especially for those living with or affected by a rare disease. The Foundation seeks eligible, disease-agnostic nonprofit organizations to help create and execute programs aligned with these priorities. “Alexion…

Read More